HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kedar, E. Articles by Fahey, J. L. Search for Related Content PubMed Articles by Kedar, E. Articles by Fahey, J. L.

Enzymatic Enhancement of Cell-Mediated Cytotoxicity and Antibody-Dependent Cell Cytotoxicity¹

From the Department of Microbiology and Immunology, University of California School of Medicine, Los Angeles, California 90024

Abstract

The effects of papain, trypsin, Pronase, neuraminidase, and phospholipase C on in vitro cell-mediated cytotoxicity (CMC) and antibody-dependent cell cytotoxicity (ADCC) have been studied in a syngeneic tumor system. Proteolytic enzyme treatment of lymphoid (effector) cells at low concentrations (<0.1 mg/ml) and for short times (less than 30 min) produced a 2- to 6-fold increase in CMC and ADCC. Neuraminidase also augmented both CMC and ADCC, whereas phospholipase C had no effect. The specificity of the cytotoxicity (CMC) amplification following enzymatic treatment was indicated by observations that: a) the activated immune cells were not cytotoxic to unrelated tumor cells, and b) normal cells were not activated.

The enzymatically induced potentiation was observed only with organs which already had demonstrable cytotoxic activity. Kinetic studies indicated that the enzymatic treatment may produce a quantitative as well as a qualitative change in the lymphoid cell population. Enzymatic treatment of lymphoid cells may be a valuable means of increasing the sensitivity of in vitro assays for cell-mediated immunity.

Pretreatment of lymphoid cells with high enzyme concentrations (over 1 mg/ml) or for prolonged periods of time (over 1 hr) did not reduce ADCC, but strongly suppressed CMC. This difference in response to proteolytic enzymes emphasizes chemical differences in the membrane components responsible for CMC vs ADCC.

Footnotes

¹ This investigation was supported by Grant CA 12800 from the National Cancer Institute, National Institute of Health, Bethesda, Maryland.

² Recipient of a traveling grant from Fulbright-Hays Foundation.